Filing Details
- Accession Number:
- 0000784199-14-000042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-15 17:01:49
- Reporting Period:
- 2014-08-13
- Filing Date:
- 2014-08-15
- Accepted Time:
- 2014-08-15 17:01:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1112830 | Ashley David Lee | Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | Executive Vp, Coo & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-13 | 9,881 | $9.73 | 238,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-13 | 9,881 | $10.51 | 228,609 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-08-14 | 119 | $9.73 | 228,728 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-14 | 119 | $10.50 | 228,609 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-13 | 9,881 | $0.00 | 9,881 | $9.73 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-14 | 119 | $0.00 | 119 | $9.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,619 | 2009-02-25 | 2015-02-25 | No | 4 | M | Direct |
| 27,500 | 2009-02-25 | 2015-02-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | By Spouse |
| Common Stock | 1,500 | Indirect | By Children |
Footnotes
- The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 5, 2014.
- Reflects weighted average price. Range of prices were between $10.50 to $10.56. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date (February 25, 2008).
Billionaire Hedge Funds
